G
Genelux Corp D
D
GNLX
2.96000
USD
0.09
(3.14%)
مغلق
حجم التداول
22,923
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
111,695,502
الأخبار المقالات
العنوان: Genelux Corp
القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.